Huhtaniemi I, Ding Y Q, Tähtelä R, Välimäki M
Department of Physiology, University of Turku, Finland.
J Clin Endocrinol Metab. 1992 Dec;75(6):1442-5. doi: 10.1210/jcem.75.6.1464645.
The purpose of this study was to find out whether the ratio of bioactive (B)/immunoreactive (I) LH varies during pulsatile LH secretion in healthy men when I-LH is determined using novel immunometric methods with improved sensitivity and specificity. Blood samples were collected for LH measurements from eight healthy men (aged 20-26 yr) at 20-min intervals over a period of 10 h. LH was measured in all samples using two novel sensitive and specific immunometric methods [Delfia, Wallac (sensitivity, 0.04 IU/L); and Amerlite, Amersham (sensitivity, 0.1 IU/L)] and for comparison with a conventional RIA. In addition, the plasma samples representing the LH secretion peaks and the preceding interpulse nadirs (two to five pairs of samples per subject; n = 23) were measured for B-LH using the mouse interstitial cell in vitro bioassay. The three immunoassay methods demonstrated the well known pulsatile mode of I-LH secretion in all subjects. A good correlation of B- and immunometric I-LH levels was observed (bioassay vs. Delfia, r = 0.89), but independent of the immunometric method used, no difference could be demonstrated between the B/I ratios of the mean basal and peak levels of LH (1.72 +/- 0.19 and 1.63 +/- 0.19 with Delfia, and 2.18 +/- 0.32 and 2.10 +/- 0.26 with Amerlite, respectively). Only when I-LH was measured by RIA was there a significant (P < 0.001) 2-fold increase in the B/I ratio in the secretion pulses. In conclusion, the previously documented increase in the B/I ratio of LH during the endogenous secretion pulses could not be documented when I-LH was measured, instead of RIA, using the novel immunometric methods. This finding further emphasizes the need for reassessment of the B/I ratio changes in LH in various physiological and clinical conditions.
本研究的目的是,当使用具有更高灵敏度和特异性的新型免疫测定方法测定免疫反应性促黄体生成素(I-LH)时,探究健康男性在促黄体生成素(LH)脉冲式分泌过程中,生物活性促黄体生成素(B-LH)与免疫反应性促黄体生成素(I-LH)的比率是否会发生变化。在10小时内,每隔20分钟从8名健康男性(年龄20 - 26岁)采集血样用于LH测定。使用两种新型灵敏且特异的免疫测定方法[Wallac公司的Delfia法(灵敏度为0.04 IU/L);以及Amersham公司的Amerlite法(灵敏度为0.1 IU/L)]对所有样本进行LH测定,并与传统放射免疫分析法(RIA)作比较。此外,使用小鼠间质细胞体外生物测定法对代表LH分泌峰值及之前脉冲间期最低点的血浆样本(每位受试者2至5对样本;共23对)进行B-LH测定。三种免疫测定方法均显示所有受试者的I-LH分泌呈众所周知的脉冲模式。观察到B-LH水平与免疫测定的I-LH水平具有良好的相关性(生物测定法与Delfia法,r = 0.89),但无论使用哪种免疫测定方法,LH平均基础水平与峰值水平的B/I比率之间均无差异(Delfia法分别为1.72±0.19和1.63±0.19,Amerlite法分别为2.18±0.32和2.10±0.26)。仅当用RIA测定I-LH时,分泌脉冲中的B/I比率才有显著升高(P < 0.001),升高了2倍。总之,当使用新型免疫测定方法而非RIA测定I-LH时,无法证实先前记录的内源性分泌脉冲期间LH的B/I比率升高。这一发现进一步强调了在各种生理和临床条件下重新评估LH中B/I比率变化的必要性。